As of right now, Core Laboratories N.V. [CLB] is trading at $16.29, climbing down -5.51%. An important factor to consider is whether the stock is rising or falling in short-term value. The CLB shares have lost -12.14% over the last week, with a monthly amount drifted -10.20%, and not seem to be holding up well over a long-time horizon.
On 27, July 2022, CORE LAB REPORTS SECOND QUARTER 2022 RESULTS FROM CONTINUING OPERATIONS. In a post published today on Yahoo Finance, SECOND QUARTER REVENUE OF $120.9 MILLION; UP 5% SEQUENTIALLY; UP 2% YEAR-OVER-YEAR.
From an analyst’s perspective:
Core Laboratories N.V. [NYSE: CLB] stock has seen the most recent analyst activity on April 18, 2022, when Piper Sandler downgraded its rating to a Underweight and also boosted its price target to $21.30 from $19.50. Previously, BofA Securities downgraded its rating to Underperform on October 18, 2021, and dropped its price target to $32. On July 09, 2021, downgrade downgraded it’s rating to Equal-Weight but maintained its price target of $40 on the stock. Citigroup downgraded its rating to a Sell and increased its price target to $36 on June 14, 2021. JP Morgan downgraded its rating to a Underweight and raised its price target to $18 on December 18, 2020. Cowen reiterated a Market Perform rating for this stock on November 11, 2020, and downed its price target to $20. In a note dated October 13, 2020, BofA Securities upgraded an Neutral rating on this stock.
Through the last year, Core Laboratories N.V.’s stock price ranged from $15.21 to $35.83. Currently, Wall Street analysts expect the stock to reach $22.13 within the next 12 months. Core Laboratories N.V. [NYSE: CLB] shares were valued at $16.29 at the most recent close of the market. An investor can expect a potential return of 35.85% based on the average price forecast.
Analyzing the CLB fundamentals
For Apple Inc, (CLB), the latest quarter sales were 120.9 billion, which represents an 1.90% increase. Gross Margin for this corporation currently stands at +17.83% with Operating Margin at +8.44%, Pretax Margin comes in at +7.67%, and Net Margin reading is +4.19%.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 15.85 points at the first support level, and at 15.41 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.11, and for the 2nd resistance point, it is at 17.93.
Core Laboratories N.V. [CLB] reported earnings per share of $0.12 for its fiscal quarter that ended on 6/29/2022. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.13/share, meaning a difference of $-0.01 and a surprise factor of -7.70%. By comparison, the stated earnings for the previous quarter ended on 3/30/2022 were $0.08 per share as compared to estimates of $0.06 per share, a difference of $0.02 representing a surprise of 33.30%.
Ratios To Look Out For
It is important to note that Core Laboratories N.V. [NYSE:CLB] has a current ratio of 2.10. On the other hand, the Quick Ratio is 1.58, and the Cash Ratio is 0.20. Considering the valuation of this stock, the price to sales ratio is 2.22, the price to book ratio is 6.61 and the P/E (TTM) ratio is 87.58.
Transactions by insiders
The next item on our agenda is insider trading, which has seen 0 insider purchases totaling 0 shares and 0 insider sales totaling 0 shares over the past 3 months.